These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 3318088)
1. BCG in management of superficial bladder cancer. Guinan P; Crispen R; Rubenstein M Urology; 1987 Dec; 30(6):515-9. PubMed ID: 3318088 [TBL] [Abstract][Full Text] [Related]
2. BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer. Bassi P Surg Oncol; 2002 Jun; 11(1-2):77-83. PubMed ID: 12031870 [TBL] [Abstract][Full Text] [Related]
3. BCG for bladder cancer. Med Lett Drugs Ther; 1991 Apr; 33(841):29-30. PubMed ID: 2002783 [No Abstract] [Full Text] [Related]
4. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer. Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662 [No Abstract] [Full Text] [Related]
5. [Treatment and follow-up of superficial bladder cancer]. Raitanen M Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168 [No Abstract] [Full Text] [Related]
6. Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials. De Jager R; Guinan P; Lamm D; Khanna O; Brosman S; De Kernion J; Williams R; Richardson C; Muenz L; Reitsma D Urology; 1991 Dec; 38(6):507-13. PubMed ID: 1836081 [TBL] [Abstract][Full Text] [Related]
7. Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group. Bouffioux C Scand J Urol Nephrol Suppl; 1991; 138():167-77. PubMed ID: 1838428 [No Abstract] [Full Text] [Related]
12. [Our experience in the treatment of superficial cancer of the bladder with BCG]. Martínez E; Díaz I; Salvador J; Viladoms JM; Zungri E; Solé-Balcells FJ Arch Esp Urol; 1989 May; 42(4):325-7. PubMed ID: 2782959 [TBL] [Abstract][Full Text] [Related]
14. Some aspects in treatment of superficial bladder cancer. Alfthan O Nihon Hinyokika Gakkai Zasshi; 1992 Jun; 83(6):802. PubMed ID: 1501383 [No Abstract] [Full Text] [Related]
15. Carcinoma in situ and treatment options. Erton M; Ilker Y; Akdaş Int Urol Nephrol; 1996; 28(1):33-42. PubMed ID: 8738617 [TBL] [Abstract][Full Text] [Related]
16. The preparation, handling and use of intravesical bacillus Calmette-Guerin for the management of stage Ta, T1, carcinoma in situ and transitional cell cancer. Brosman SA; Lamm DL J Urol; 1990 Aug; 144(2 Pt 1):313-5. PubMed ID: 2374197 [TBL] [Abstract][Full Text] [Related]
17. Bladder carcinoma--the good, the bad and the ugly. Manyak MJ J Urol; 1996 Jan; 155(1):103-4. PubMed ID: 7490802 [No Abstract] [Full Text] [Related]